Home Cart Sign in  
Chemical Structure| 1070790-89-4 Chemical Structure| 1070790-89-4

Structure of Fadraciclib
CAS No.: 1070790-89-4

Chemical Structure| 1070790-89-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fadraciclib, also known as CYC065, is an orally bioavailable inhibitor of cyclin dependent kinases 2, 5 and 9 (CDK2/5/9) with potential antineoplastic and chemoprotective activities. CYC065 selectively binds to and inhibits the activity of CDK2, 5 and 9, which leads to inhibition of CDK2, 5 and 9-dependent cellular pathways, downregulation of genes involved in the pro-survival pathway, prevention of the activation of DNA double-strand break repair pathways, and induction of both cell cycle arrest and apoptosis. This inhibits the proliferation of CDK2/5/9-overexpressing tumor cells. In addition, CYC065 protects hematopoietic stem and progenitor cells (HSPCs), prevents myelosuppression, and preserves the function of the bone marrow.

Synonyms: CYC065

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fadraciclib

CAS No. :1070790-89-4
Formula : C21H31N7O
M.W : 397.52
SMILES Code : C[C@@H](O)[C@@H](NC1=NC(NCC2=C(C)C=C(C)N=C2)=C3N=CN(C(C)C)C3=N1)CC
Synonyms :
CYC065
MDL No. :MFCD31693062
InChI Key :DLPIYBKBHMZCJI-WBVHZDCISA-N
Pubchem ID :24983461

Safety of Fadraciclib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Related Pathways of Fadraciclib

Hedgehog

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04983810 Solid Tumor, Adult|Lymphoma PHASE1|PHASE2 RECRUITING 2025-06-30 City of Hope, Duarte, Californ... More >>ia, 91010, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Seoul National University Hospital, Seoul, Korea, Republic of|Hospital Universitario Vall d'Hebron, Barcelona, Spain Less <<
NCT02552953 Cancer PHASE1 COMPLETED 2023-08-25 Dana-Farber Cancer Institute, ... More >>Boston, Massachusetts, 02215, United States Less <<
NCT05817890 Healthy EARLY_PHASE1 COMPLETED 2024-05-22 Labcorp Clinical Research Unit... More >>, Madison, Wisconsin, 53704, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.52mL

0.50mL

0.25mL

12.58mL

2.52mL

1.26mL

25.16mL

5.03mL

2.52mL

References

 

Historical Records

Categories